藥品參考
Epirubicin
Epirubicin is a medicine in the class oncology. It is used for breast cancer.
- 藥物類別: Oncology
- 用途: breast cancer
最後更新
僅供醫療專業人員參考。本頁為簡要摘要，並非醫療建議，亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。
本頁的臨床內容僅提供英文版。
重點資訊
- 藥物類別
- Oncology
- 常見劑型
- 注射劑, 輸注液
- 常見規格
- 10 mg/5 ml, 50 mg/25 ml, 50 mg
- 已知交互作用
- 23 (禁忌併用: 1 · 嚴重: 11 · 中度: 9 · 輕微: 2)
- 商品名
- 26
- 國家與市場
- 4
用途
作用方式
Anthracycline; intercalates between DNA base pairs and triggers cleavage by topoisomerase II, which results in cytocidal activity. Inhibits DNA helicase and generates cytotoxic free radicals.
成人常用劑量（仿單摘要）
Adjuvant Breast Cancer Treatment: Day 1: Epirubicin 100 mg/m² IV, AND 5-fluorouracil 500 mg/m² IV, AND cyclophosphamide 500 mg/m² IV
懷孕與哺乳
- 懷孕
- Unsafe Can cause fetal harm; avoid in the 1st trimester. Fetal and newborn heart toxicity has been reported after exposure. Any later use for cancer needs specialist care. Women: effective contraception during and for 6 months after the last dose.
- 哺乳
- Unsafe No human milk data; present in rat milk. Do not breastfeed during treatment and for at least 7 days after the last dose (LactMed: at least 8 days, based on half-life).
已通報的副作用
- Vomiting
- Nausea
- Leukopenia
- Anemia
- Neutropenia
- Alopecia
哪些人需要特別留意
- Administration of live or live-attenuated vaccines in patients immunocompromised by chemotherapeutic agents may result in serious or fatal infections
- Administration after previous radiation therapy may induce an inflammatory recall reaction at site of irradiation
- Therapy can cause fetal harm; advise patients of potential risk to a fetus and to use effective contraception
請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏，以及您正在使用的所有其他藥物或保健品。
重要交互作用 (23)
- Adenovirus types 4 and 7 live + Epirubicin Contraindicated
- Belatacept + Epirubicin Major
- Cimetidine + Epirubicin Major
- Deferiprone + Epirubicin Major
- Dengue vaccine + Epirubicin Major
- Epirubicin + Etrasimod Major
- Epirubicin + Fingolimod Major
- Epirubicin + Ropeginterferon alfa 2b Major
- Epirubicin + Siponimod Major
- Epirubicin + Tofacitinib Major
同類別的其他藥品
常見問題
What is Epirubicin used for?
Epirubicin is a medicine in the class oncology. It is used for Breast cancer.
What side effects have been reported with Epirubicin?
Vomiting, Nausea, Leukopenia, Anemia, Neutropenia, Alopecia.
Can Epirubicin be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm; avoid in the 1st trimester. Fetal and newborn heart toxicity has been reported after exposure. Any later use for cancer needs specialist care. Women: effective contraception during and for 6 months after the last dose. Breastfeeding: Unsafe. No human milk data; present in rat milk. Do not breastfeed during treatment and for at least 7 days after the last dose (LactMed: at least 8 days, based on half-life).
What does Epirubicin interact with?
MediHelp lists 23 known interactions for Epirubicin. Contraindicated: 1 · Major: 11 · Moderate: 9 · Minor: 2. The most serious include Adenovirus types 4 and 7 live, Belatacept, Cimetidine.
在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查
在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用，並使用劑量工具。
